El mercado mundial de pruebas de marcadores cardíacos se valoró en USD 3900 millones en 2021 y se prevé que crezca a una tasa compuesta anual del 10,4 % durante el período de pronóstico para alcanzar los USD 10500 millones en 2031.
Los marcadores cardíacos se utilizan en el tratamiento y la estratificación del riesgo de pacientes con sospecha de síndrome coronario agudo (SCA). Las pruebas de troponina I y T, HDCRP, mioglobina, CK-MB y otros marcadores cardíacos se encuentran entre las más comunes. Cuando el corazón está estresado o lesionado, se liberan en la sangre sustancias llamadas marcadores cardíacos. Las hormonas, las enzimas y las proteínas son ejemplos de estos marcadores. Estos biomarcadores pueden ser útiles para detectar una variedad de trastornos cardíacos, que comprenden el síndrome coronario agudo, la isquemia cardíaca y afecciones que involucran la obstrucción del flujo sanguíneo al corazón. Los médicos realizan varias pruebas de marcadores cardíacos durante varias horas para realizar un seguimiento del aumento de azúcar en la sangre y determinar la gravedad de un ataque al corazón.
Para mantenerse ‘por delante’ de sus competidores, solicite una muestra: https://www.globalinsightservices.com/request-sample/GIS10254
Jugadores clave en el mercado mundial Pruebas de marcadores cardiacos
Los actores clave en el mercado mundial de pruebas de marcadores cardíacos son Roche Diagnostics Ltd. (Suiza), Abbott Laboratories (EE. UU.), Siemens Healthineers AG (Alemania), Danaher Corporation (EE. UU.), bioMérieux SA (Francia), LSI Medience Corporation (Japón) , Ortho Clinical Diagnostics (EE. UU.), Randox Laboratories Ltd. (Reino Unido), Guangzhou Wondfo Biotech Co., Ltd (China), DiaSorin SpA (Italia), Becton, Dickinson and Company (EE. UU.), Bio-Rad Laboratories, Inc. ( EE. UU.), PerkinElmer Inc. (EE. UU.), Thermo Fisher Scientific Inc. (EE. UU.), Tosoh Corporation (Japón).
Segmentos de mercado
por producto
- Reactivos y kits
- Instrumentos
Obtenga un informe personalizado según sus requisitos: https://www.globalinsightservices.com/request-customization/GIS10254
Tendencias y conductores del mercado
The key factor boosting the growth of the market is the growing incidence of cardiovascular diseases. The prevalence of lifestyle diseases such as hypertension, obesity, dyslipidemia, and diabetes, which are major risk factors for CVD, is also on the rise. In 2016, more than 1.9 billion adults globally were overweight; of these, over 600 million people were obese. It is anticipated that ~41% of the world’s population will be overweight or obese by 2030. The association between obesity and the risk of coronary heart disease was published by investigators (Bogers RP, Bemelmans WJ, Hogeveen RT, et al.) by a meta-analysis of 21 long-term studies conducted by them with more than 300,000 participants. It was witnessed that participants who were overweight had a 32% higher risk of developing coronary artery disease (CAD), and those who were obese had an 81% higher risk as compared with participants who were a normal weight.
For In-Depth Competitive Analysis, Purchase this Report – https://www.globalinsightservices.com/inquiry-before-buying/GIS10254
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm
headquartered in Delaware, US. We are committed to providing our clients
with highest quality data, analysis, and tools to meet all their market research
needs. With GIS, you can be assured of the quality of the deliverables, robust
and transparent research methodology, and superior service.
Contáctenos:
Global Insight Services LLC
16192, Carretera Costera, Lewes DE 19958
Correo electrónico: [email protected]
Teléfono: +1-833-761-1700